Lu-177-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma

Malenge, MM; Patzke, S; Ree, AH; Stokke, T; Ceuppens, P; Middleton, B; Dahle, J; Repetto-Llamazares, AHV

Dahle, J (corresponding author), Nordic Nanovector ASA, Kjelsasveien 168B, N-0884 Oslo, Norway.

JOURNAL OF NUCLEAR MEDICINE, 2020; 61 (10): 1468

Abstract

Patients with non-Hodgkin lymphoma (NHL) who are treated with rituximab may develop resistant disease, often associated with changes in expression of ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索